Yesterday, the internet quivered with outrage as word spread of a drug company’s decision to deny giving an experimental drug to a 7-year-old boy dying of heart and kidney failure.
Josh Hardy had beaten cancer 4 times. But he needed brincidofovir, and Chimerix said no. It would cost $50,000 — because insurance does not pay for experimental drugs — and, the company president said, would divert manpower in the 50-person company. According to reports, Chimerix has $110 million in the bank.
Around the country, people used social media to put pressure on Chimerix. Westporters joined in — and found special reason to demand action.
Canaan controls one of Chimerix’s board seats. They could have nudged — or pushed — the company to take action.
Whether they did or not is unknown. But last night, Chimerix agreed to provide the medication to a boy who, without it, was almost certain to die.